Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Coiled-coil domain-containing protein 32 (CCDC32) is a protein encoded by the CCDC32 gene, implicated in the assembly of adaptor protein complex 2 (AP2), crucial for clathrin-mediated endocytosis in eukaryotic cells[1]. CCDC32 acts as a selective and essential assembly chaperone, specifically regulating the formation of the AP2 adaptor complex via interaction with its α, σ2, and μ2 subunits, facilitating correct assembly sequence and stability[1]. Additionally, CCDC32 has an evolutionarily conserved role in ciliogenesis, being required for the formation and/or maintenance of cilia necessary for vertebrate left-right axis development. Loss-of-function mutations in CCDC32 are linked to congenital syndromes characterized by craniofacial, cardiac, and neurodevelopmental defects[2]. While it interacts with annexin A2, the broader molecular role remains incompletely defined[2]. There are currently no approved drugs, known mechanisms of drug targeting, validated biomarkers, or explicit safety concerns associated with CCDC32.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Coiled-coil domain-containing protein 32 (CCDC32).